Citigroup’s Aehr Test Systems AEHR Stock Holding History

Citigroup’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70,900	Closed	-$2.63M	–	5687
2026 Q1	$2.63M	Buy	+70,900	New	+$2.27M	﹤0.01%	2496

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup's AEHR Position: Q2 2026 in Review

Citigroup increased its Aehr Test Systems (AEHR) stake by 426% in Q2 2026, buying an estimated $2.78M and bringing the position to 37,518 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

Citigroup first reported a position in AEHR in Q4 2021 and has held it in 18 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Citigroup held 37,518 shares of Aehr Test Systems worth $3.6M as of Q2 2026.
Citigroup bought 30,390 Aehr Test Systems shares in Q2 2026, an estimated $2.78M.
Aehr Test Systems made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2425 holding.
Citigroup first reported a position in Aehr Test Systems in Q4 2021 and has held it in 18 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.